Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results

Publisher： Karger

E-ISSN： 1421-9794|60|5-6|294-299

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.5-6, 2015-0, pp. : 294-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy

By Chen Wei   Bepler Gerold  

Journal of Personalized Medicine, Vol. 3, Iss. 3, 2013-09 ,pp. : 251-262

MDPI

Access to resources Recommend Favorite

Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer

By Xiao Jie   Xu Xiaobo   Li Xiao   Li Yanli   Liu Guobing   Tan Hui   Shen Hua   Shi Hongcheng   Cheng Dengfeng  

Molecules, Vol. 21, Iss. 10, 2016-09 ,pp. : 1308-1308

MDPI

Access to resources Recommend Favorite

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer

By Tomasini Pascale   Serdjebi Cindy   Khobta Nataliya   Metellus Philippe   Ouafik L’Houcine   Nanni Isabelle   Greillier Laurent   Loundou Anderson   Fina Frederic   Mascaux Celine   Barlesi Fabrice  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2132-2132

MDPI

Access to resources Recommend Favorite

CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain

By Cavallaro Sebastiano  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 1713-1727

MDPI

Access to resources Recommend Favorite

Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutation

By  

Chemotherapy, Vol. 59, Iss. 6, 2014-07 ,pp. : 414-419

Karger

Access to resources Recommend Favorite